Literature DB >> 17964281

SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity.

Tie Zou1, Raju Ilangovan, Furong Yu, Zuoshang Xu, Jianhua Zhou.   

Abstract

Deletion or mutation of the survival of motor neuron (SMN1) gene causes Spinal Muscular Atrophy (SMA), a motor neuron degenerative disease. To study the SMN function, we co-transfected mouse NSC34 cells with SMN and mutant superoxide dismutase 1 (SOD1) constructs. We demonstrated that SMN protected NSC34 cells against cell death induced by mutant SOD1 under oxidative stress. Further studies indicated that over-expression of wild-type SMN up-regulated chaperone activity. In contrast, chaperone activity was decreased in cells expressing SMN mutant Y272C or in cells with SMN suppressed by shRNA. In vitro assays using bacteria lysates expressing GST-SMN or purified GST-SMN protein showed that the GST-SMN reduced catalase aggregation, indicating that SMN may possess chaperone activity. We conclude that SMN plays a protective role in motor neurons by its chaperone activity. Our results provide support for the potential development of therapy for SMA and amyotrophic lateral sclerosis (ALS).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964281      PMCID: PMC2169267          DOI: 10.1016/j.bbrc.2007.10.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Gemin5, a novel WD repeat protein component of the SMN complex that binds Sm proteins.

Authors:  Amelie K Gubitz; Zissimos Mourelatos; Linda Abel; Juri Rappsilber; Matthias Mann; Gideon Dreyfuss
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

2.  Purification of native survival of motor neurons complexes and identification of Gemin6 as a novel component.

Authors:  Livio Pellizzoni; Jennifer Baccon; Juri Rappsilber; Matthias Mann; Gideon Dreyfuss
Journal:  J Biol Chem       Date:  2001-12-17       Impact factor: 5.157

3.  The survival motor neuron protein in spinal muscular atrophy.

Authors:  D D Coovert; T T Le; P E McAndrew; J Strasswimmer; T O Crawford; J R Mendell; S E Coulson; E J Androphy; T W Prior; A H Burghes
Journal:  Hum Mol Genet       Date:  1997-08       Impact factor: 6.150

4.  Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity?

Authors:  C J DiDonato; S E Ingraham; J R Mendell; T W Prior; S Lenard; R T Moxley; J Florence; A H Burghes
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

5.  Molecular chaperones protect catalase against thermal stress.

Authors:  D W Hook; J J Harding
Journal:  Eur J Biochem       Date:  1997-07-01

6.  An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene.

Authors:  D W Parsons; P E McAndrew; U R Monani; J R Mendell; A H Burghes; T W Prior
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

7.  Survival motor neuron protein modulates neuron-specific apoptosis.

Authors:  D A Kerr; J P Nery; R J Traystman; B N Chau; J M Hardwick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

8.  Identification and characterization of a spinal muscular atrophy-determining gene.

Authors:  S Lefebvre; L Bürglen; S Reboullet; O Clermont; P Burlet; L Viollet; B Benichou; C Cruaud; P Millasseau; M Zeviani
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

9.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

10.  Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli.

Authors:  B Charroux; L Pellizzoni; R A Perkinson; J Yong; A Shevchenko; M Mann; G Dreyfuss
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  18 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  Drug treatment for spinal muscular atrophy types II and III.

Authors:  Renske I Wadman; W Ludo van der Pol; Wendy Mj Bosboom; Fay-Lynn Asselman; Leonard H van den Berg; Susan T Iannaccone; Alexander Fje Vrancken
Journal:  Cochrane Database Syst Rev       Date:  2020-01-06

3.  Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.

Authors:  Barry Gertz; Margaret Wong; Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

4.  Nanomolar naloxone attenuates neurotoxicity induced by oxidative stress and survival motor neuron protein deficiency.

Authors:  Ya-Yun Hsu; Yuh-Jyh Jong; Yu-Ting Lin; Yu-Ting Tseng; Shih-Hsien Hsu; Yi-Ching Lo
Journal:  Neurotox Res       Date:  2013-07-27       Impact factor: 3.911

5.  Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.

Authors:  Shingo Kariya; Diane B Re; Arnaud Jacquier; Katelyn Nelson; Serge Przedborski; Umrao R Monani
Journal:  Hum Mol Genet       Date:  2012-05-11       Impact factor: 6.150

6.  Proteomic assessment of a cell model of spinal muscular atrophy.

Authors:  Chia-Yen Wu; Dosh Whye; Lisa Glazewski; Leila Choe; Douglas Kerr; Kelvin H Lee; Robert W Mason; Wenlan Wang
Journal:  BMC Neurosci       Date:  2011-03-08       Impact factor: 3.288

7.  Homozygous SMN2 deletion is a major risk factor among twenty-five Korean sporadic amyotrophic lateral sclerosis patients.

Authors:  Jun-Beom Lee; Kyung-A Lee; Ji-Man Hong; Gyoung-Im Suh; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

8.  Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity.

Authors:  Tali Gidalevitz; Thomas Krupinski; Susana Garcia; Richard I Morimoto
Journal:  PLoS Genet       Date:  2009-03-06       Impact factor: 5.917

9.  Progranulin is expressed within motor neurons and promotes neuronal cell survival.

Authors:  Cara L Ryan; David C Baranowski; Babykumari P Chitramuthu; Suneil Malik; Zhi Li; Mingju Cao; Sandra Minotti; Heather D Durham; Denis G Kay; Christopher A Shaw; Hugh P J Bennett; Andrew Bateman
Journal:  BMC Neurosci       Date:  2009-10-27       Impact factor: 3.288

10.  Drug treatment for spinal muscular atrophy type I.

Authors:  Renske I Wadman; W Ludo van der Pol; Wendy Mj Bosboom; Fay-Lynn Asselman; Leonard H van den Berg; Susan T Iannaccone; Alexander Fje Vrancken
Journal:  Cochrane Database Syst Rev       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.